ARCHITECT ANTI-HCV

Assay, Enzyme Linked Immunosorbent, Hepatitis C Virus

FDA Premarket Approval P050042 S002

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Approval to extend the expiration dating of reagents, calibrators, and controls to 14 months. The device, as modified, will be marketed under the trade name architect anti-hcv and is indicated for the qualitative detection of immunoglobulin g (igg) and immunoglobulin m (igm) antibodies to hepatitis c virus (anti-hcv) in human adult and pediatric serum and plasma (potassium edta, lithium heparin, and sodium heparin).

DeviceARCHITECT ANTI-HCV
Classification NameAssay, Enzyme Linked Immunosorbent, Hepatitis C Virus
Generic NameAssay, Enzyme Linked Immunosorbent, Hepatitis C Virus
ApplicantABBOTT LABORATORIES INC
Date Received2007-01-11
Decision Date2007-03-05
PMAP050042
SupplementS002
Product CodeMZO
Advisory CommitteeMicrobiology
Supplement TypeReal-time Process
Supplement ReasonLabeling Change - Indications/instructions/shelf Life/tradename
Expedited ReviewNo
Combination Product No
Applicant Address ABBOTT LABORATORIES INC 100 Abbott Park Road ap5n-2, Dept 09vb abbott Park, IL 60064

Supplemental Filings

Supplement NumberDateSupplement Type
P050042Original Filing
S047 2021-11-18 30-day Notice
S046 2021-11-09 30-day Notice
S045 2021-02-09 Real-time Process
S044 2020-07-31 30-day Notice
S043 2020-04-08 30-day Notice
S042
S041
S040
S039 2019-07-18 30-day Notice
S038 2018-12-28 30-day Notice
S037 2018-10-12 30-day Notice
S036 2018-10-10 30-day Notice
S035 2018-09-21 30-day Notice
S034
S033 2016-02-29 30-day Notice
S032 2015-07-16 30-day Notice
S031 2014-11-13 30-day Notice
S030 2014-09-19 30-day Notice
S029 2014-04-01 30-day Notice
S028 2013-10-30 30-day Notice
S027 2013-10-28 30-day Notice
S026 2013-10-18 30-day Notice
S025 2013-08-05 30-day Notice
S024 2013-04-23 30-day Notice
S023 2013-02-15 30-day Notice
S022 2013-02-11 30-day Notice
S021 2012-11-19 30-day Notice
S020 2012-11-15 30-day Notice
S019 2012-11-13 30-day Notice
S018 2012-08-03 30-day Notice
S017 2012-07-05 30-day Notice
S016 2012-03-15 30-day Notice
S015 2011-11-23 Special (immediate Track)
S014 2011-10-28 30-day Notice
S013 2011-05-25 30-day Notice
S012 2011-05-04 Normal 180 Day Track No User Fee
S011 2011-04-18 30-day Notice
S010 2011-02-17 Normal 180 Day Track No User Fee
S009 2011-01-19 30-day Notice
S008 2010-12-22 Special (immediate Track)
S007 2010-11-01 Normal 180 Day Track No User Fee
S006 2010-08-02 Normal 180 Day Track No User Fee
S005 2009-01-28 Normal 180 Day Track
S004 2008-12-23 30-day Notice
S003 2007-10-29 Real-time Process
S002 2007-01-11 Real-time Process
S001 2006-06-08 135 Review Track For 30-day Notice

NIH GUDID Devices

Device IDPMASupp
00380740001421 P050042 002
00380740001414 P050042 002
00380740001407 P050042 002
00380740001391 P050042 002
00380740130657 P050042 034
00380740130640 P050042 034
00380740130633 P050042 034

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.